3.46 USD
↘ 0.76 (17.90%)LIVE (AS OF 01:57 PM EST)
Shares of Relmada Therapeutics, Inc. Common Stock (RLMD) are trading at $3.46. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, RLMD appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.